Recent Quotes
"We believe VIV is at an inflection point with significant sales increases just around the corner and presents a favorable risk/reward proposition."
—
Joseph Gomes, Noble Capital Markets
(5/4/21)
more >
"VIV received a purchase order for 4.4 mt of OxC-beta Livestock."
—
Joseph Gomes, Noble Capital Markets
(4/26/21)
more >
"Another manuscript on benefits of VIV's OxC-beta will be published."
—
Joseph Gomes, Noble Capital Markets
(3/5/21)
more >
"We are initiating research coverage on VIV with an Outperform rating."
—
Joseph Gomes, Noble Capital Markets
(3/1/21)
more >
"We continue to view favorably HOTR's business strategy and growth prospects."
—
Joseph Gomes, Wm Smith & Co.
(8/16/15)
more >
